Type 2 Diabetes Clinical Studies - Rocky Mountain Clinical Research

NN9924-4635

This trial is a 68 week double blind trial evaluating 3 doses of semaglutide in people with type 2 diabetes.

LY3819253 & LY3832479 COVID-19: Clinical Study

Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.

Oral Insulin

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects with Type 2 Diabetes Mellitus

Ricolinostat

Study of Ricolinostat in Patients With Diabetic Neuropathy Pain

Semaglutide

Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes

Eli Lilly ITSW

A Study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring

GPHD

This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.

Eli Lilly BDCL

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Can’t find a study that works for you?

Subscribe for Information on Other Studies

Fill out the form below an we will let you know when a study becomes available that you may be interested in: